Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
CRISPR THERAP N (NQ: CRSP)
47.27 USD  -2.33 (-4.70%)
Official Closing Price  /  Updated: 8:00 PM EDT, Apr 24, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,290,666
Open 50.00
Bid (Size) 47.70 (200)
Ask (Size) 47.91 (100)
Prev. Close 49.60
Today's Range 46.35 - 51.72
52wk Range 13.50 - 61.24
Shares Outstanding 46,003,674
Dividend Yield N/A
Performance
YTD
+87.80%
+87.80%
1 Month
-9.57%
-9.57%
3 Month
+21.89%
+21.89%
6 Month
+145.05%
+145.05%
1 Year
+185.10%
+185.10%
Top News
More News
Trump threatens China with additional tariffs, markets plunge
President Donald Trump threatened to impose tariffs on an additional $100 billion of imports from China. The markets tumbled to open lower with the Dow plunging 132 points to 24,373. Nasdaq plummeted... Read More
category Market News
from MarketMinute.com Market Updates
CRISPR Therapeutics Presents Positive Data on Allogeneic CRISPR-based CAR-T Cell Therapies at AACR 2018
CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced the presentation of new data from the... Read More
from GlobeNewswire News Releases
More News
Read More
CRISPR Therapeutics to Present Data on Allogeneic CRISPR-based CAR-T Cell Therapies at AACR 2018
from GlobeNewswire News Releases
Market Trends Toward New Normal in Argo Group International, Methanex, Industrias Bachoco, S.A. de C.V, CRISPR Therapeutics AG, Astec Industries, and Sprague Resources LP — Emerging Consolidated Expec
from GlobeNewswire News Releases
CRISPR Therapeutics Announces the Appointment of Steve Caffé as Head of Regulatory Affairs
from GlobeNewswire News Releases
CRISPR Therapeutics Announces the Retirement of Tyler Dylan-Hyde and Appointment of Shelby Walker as Head of Intellectual Property
from GlobeNewswire News Releases
Pfizer Takes On Gilead, Novartis With New Deal In Cancer Drugs
from Investor's Business Daily
Analysis: Positioning to Benefit within CURO Group, Golar LNG Partners LP, CRISPR Therapeutics AG, Kinross Gold, Enerplus, and ManTech International — Research Highlights Growth, Revenue, and Consolid
from GlobeNewswire News Releases
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2017 Financial Results
from GlobeNewswire News Releases
Biotech And Pharma Stocks Await Q1 Earnings But Gene Editing Stocks Sell-Off
category Stocks / Equities , Pharma/Biotech , Healthcare
from Blogs - TalkMarkets
Geron Corporation: The Clock Is Ticking
category JNJ , CRSP , GERN
from Motley Fool
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial